On July 1, 2018 the Controlled Substance Bill became effective in the state of Florida. “There is nothing about this law that means legitimate patients cannot get legitimate medicine for legitimate reasons,” Dr. John Ellington, who is in charge of risk management at the 200-physician Watson Clinic in Lakeland, Florida is quoted as saying.
With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.
In recent years, the opioid abuse epidemic has taken center stage in the United States. From stories in local newspapers, to nuanced discussions about the best policy solutions Washington can offer, it seems most people are in some way aware of the current crisis. One of the most effective methods used to combat the rise in narcotic-related overdoses has been the implementation of prescription drug monitoring programs (PDMPs) by 49 of 50 states. These systems help to track controlled substances – who is prescribing them, who is receiving them, how much is prescribed and how often, etc. While there is a lot of emphasis on the role physicians play in PDMPs being a meaningful tool, an important member of the healthcare team is often overlooked – the pharmacist.
The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.